Answers are grounded in this paper and cite their sources.
Objective To describe the geographic distribution and clinical features of dogs and cats with Baylisascaris procyonis detected by fecal quantitative PCR (qPCR). Methods Dogs and cats in the US and Canada that were diagnosed with B procyonis via fecal qPCR performed by a veterinary diagnostic laboratory from March 3, 2022, through November 1, 2023, were identified. Details about patient demographics, clinical signs, treatment, and outcome were retrospectively captured via questionnaires sent to each pet’s primary care veterinarian. Descriptive statistics were calculated. Results B procyonis was detected in 74 dogs and 3 cats through fecal qPCR screening. Dogs were from Canada (n = 22) and the US (52), and cats were from the US (3). The US-detected samples were from the Midwest (35%) and Northeast (22%). Most US-detected cases (69%) resided in a suburban environment, and most Canadian cases (80%) resided in an urban environment. Clinical signs were not reported in most (62%) cases with fecal qPCR-detected B procyonis . Gastrointestinal signs were reported in 36% of cases, and resolution of gastrointestinal signs following anthelmintic treatment was reported in most (72.9%) of those. Conclusions The geographic distribution of detected B procyonis in dogs and cats is similar to that reported in raccoons. Reported clinical disease appears mild and responsive to anthelmintic treatment in most dogs and cats. Clinical Relevance Veterinarian awareness of risk regions for raccoon roundworm detection is critical for One Health. Detection of B procyonis through routine fecal screening of dogs and cats informs risk of environmental exposure and zoonoses and allows for targeted antiparasitic prevention.
No takes yet. Share an insight, caveat, or question.
Teng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: